^
    over1year
    SHR9549 in ER Positive HER2 Negative Advanced Breast Cancer (clinicaltrials.gov)
    P1, N=4, Terminated, Jiangsu HengRui Medicine Co., Ltd. | N=44 --> 4 | Unknown status --> Terminated; Sponsor R & D Strategy Adjustment
    Enrollment change • Trial termination
    |
    HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
    |
    ER positive • HER-2 negative
    |
    SHR9549